The current state of genomic testing in bladder cancer

In this video, Seth P. Lerner, MD, FACS, discusses current and projected advances in genomic testing for bladder cancer, which were topics he focused on in his recent presentation at the 2021 Society of Urologic Oncology Annual Meeting. Lerner is a professor of urology, Beth and Dave Swalm Chair in urologic oncology, director of urologic oncology, and director of the Multidisciplinary Bladder Cancer Program at the Baylor College of Medicine, Houston, Texas.